Ottawa Hospital Research Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Ottawa Hospital Research Institute brings 6 presentations to ASH 2026 in New Orleans. Its program centres on blood clots and bleeding. Research covers JAK2 clonal hematopoiesis after a first clot, clots linked to cancer and pregnancy-related clots in Ontario.
| Organization | ASH 2026 Attendance |
|---|---|
Ottawa Hospital Research Institute Ottawa, Canada | |
Research institute of The Ottawa Hospital, affiliated with the University of Ottawa. | Session Fri Dec 11 3:04pm–4:25pm Translational Studies in Cancer-Associated Thrombosis How immune checkpoint drugs, extracellular vesicles, tumor-vessel contact and metabolism push cancer patients toward forming blood clots. Poster Sat Dec 12 5:30pm–7:30pm Oral Sun Dec 13 9:30am–11:00am Talk Sun Dec 13 4:30pm–5:45pm Clones and Clots: Clonal Hematopoiesis in the Management of Venous Thromboembolism Whether clonal hematopoiesis predicts blood clots in veins, their recurrence and bleeding on blood thinners, and what that means for anticoagulation decisions. Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm |
Find decision makers at Ottawa Hospital Research Institute
Tell us what you sell and we’ll find the people at Ottawa Hospital Research Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction